JACKSONVILLE, Fla., June 15 /PRNewswire/ -- A study published in the May/June issue of "Endocrine Practice" finds that many diabetes patients can have better control of their blood sugar with a simple adjustment in their insulin dosage. The study showed that Type 1 diabetes patients currently using insulin pump therapy controlled their blood sugar levels more effectively by adjusting their mealtime therapy dosage.
Nearly 80,000 patients currently use insulin pumps in this country. It is growing in popularity partly because it is less of a burden on the patient than traditional insulin therapy.
During the 14-month study, blood sugar levels improved without weight gain when mealtime therapy is applied. Hemoglobin A1c levels which represent GlucoseAverage(TM) were lowered from 8.4% to 7.7%. The American Association of Clinical Endocrinologists, which publishes "Endocrine Practice," advocates a Hemoglobin A1c level of 7 percent or less, and ideally within the normal range of 4 to 6 percent.
Insulin pump therapy helps the patient:
AACE is a professional medical organization with over 3,400 members in the United States and 50 other countries. Founded in 1991, AACE is dedicated to the optimal care of patients with endocrine problems. AACE initiatives inform the public about endocrine diseases. AACE also conducts continuing education programs for clinical endocrinologists, physicians whose advanced, specialized training enables them to be experts in the care of endocrine disease, such as diabetes, thyroid disorders, growth hormone deficiency, osteoporosis, cholesterol disorders, hypertension and obesity.
For further information on AACE's medical guidelines on diabetes care and other endocrine disorders visit http://www.aace.com.
SOURCE American Association of Clinical Endocrinologists
CO: American Association of Clinical Endocrinologists